Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock Has Consensus Target Price of $21.50 According to Brokerages

Key Points

• Analyst sentiment is moderately positive: Seven analysts rate Sabra Healthcare REIT a buy and seven rate it a hold, producing a “Moderate Buy” consensus and an average 12-month price target of $21.50.
• Quarterly results were mixed: Revenue rose 24.7% year over year to $230.11 million and exceeded estimates, but the company reported a loss of $0.10 per share versus expectations for $0.17 in earnings.
• Sabra maintains a high dividend yield: Its quarterly dividend is $0.30 per share, equivalent to $1.20 annually and a 6.3% yield; the payout ratio stands at 461.54%. CEO Richard Matros also sold 200,000 shares under a pre-arranged trading plan.

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) has received a consensus rating of "Moderate Buy" from the fourteen analysts that are covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $21.50.

SBRA has been the topic of a number of research reports. Weiss Ratings lowered Sabra Healthcare REIT from a "hold (c+)" rating to a "hold (c)" rating in a research report on Thursday, October 8th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Truist Financial boosted their price target on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a "buy" rating in a research note on Wednesday, July 22nd. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an "underperform" rating to a "market perform" rating in a report on Thursday, August 6th. Finally, Robert W. Baird raised their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "neutral" rating in a research note on Monday, August 31st.

Insider Buying and Selling at Sabra Healthcare REIT

In related news, CEO Richard Matros sold 200,000 shares of the firm's stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the transaction, the chief executive officer owned 1,657,686 shares of the company's stock, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of hedge funds have recently added to or reduced their stakes in SBRA. Versant Capital Management Inc boosted its holdings in Sabra Healthcare REIT by 70.0% during the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust's stock worth $29,000 after purchasing an additional 603 shares during the last quarter. Mather Group LLC. grew its position in Sabra Healthcare REIT by 34,550.0% in the 3rd quarter. Mather Group LLC. now owns 2,772 shares of the real estate investment trust's stock worth $55,000 after purchasing an additional 2,764 shares in the last quarter. Integrated Wealth Concepts LLC bought a new stake in Sabra Healthcare REIT in the 2nd quarter worth about $61,000. Ameritas Advisory Services LLC purchased a new stake in Sabra Healthcare REIT in the 2nd quarter valued at about $82,000. Finally, EverSource Wealth Advisors LLC increased its stake in Sabra Healthcare REIT by 21.0% in the 1st quarter. EverSource Wealth Advisors LLC now owns 4,708 shares of the real estate investment trust's stock valued at $91,000 after buying an additional 817 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Healthcare REIT Stock Down 1.3%

SBRA stock opened at $19.08 on Tuesday. The stock's 50 day simple moving average is $20.03 and its 200 day simple moving average is $20.07. The company has a market cap of $4.87 billion, a P/E ratio of 73.39, a price-to-earnings-growth ratio of 1.47 and a beta of 0.63. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. Sabra Healthcare REIT has a fifty-two week low of $17.17 and a fifty-two week high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of $0.17 by ($0.27). The firm had revenue of $230.11 million during the quarter, compared to analyst estimates of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The company's revenue was up 24.7% on a year-over-year basis. During the same period last year, the business posted $0.38 EPS. On average, research analysts expect that Sabra Healthcare REIT will post 1.52 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 6.3%. Sabra Healthcare REIT's payout ratio is presently 461.54%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.